Blood Research

Cited by CrossRef (12)

  1. Clémence Haméon, Antoine Machet, Laurianne Drieu La Rochelle, Nicolas Vallet, Julien Lejeune, Noémie Ravalet, Jean‐Philippe Cottier, Olivier Hérault, Emmanuel Gyan. Cerebral localization of chronic myelomonocytic leukemia and improvement with high‐dose cytarabine: A case report. eJHaem 2023;4:844
    https://doi.org/10.1002/jha2.740
  2. F. Nguyen-Khac, A. Bidet, A. Daudignon, M. Lafage-Pochitaloff, G. Ameye, C. Bilhou-Nabéra, E. Chapiro, M. A. Collonge-Rame, W. Cuccuini, N. Douet-Guilbert, V. Eclache, I. Luquet, L. Michaux, N. Nadal, D. Penther, B. Quilichini, C. Terre, C. Lefebvre, M.-B. Troadec, L. Véronèse. The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH). Leukemia 2022;36:1451
    https://doi.org/10.1038/s41375-022-01561-w
  3. Konstantinos Liapis, Ioannis Kotsianidis. Approaching First-Line Treatment in Patients With Advanced CMML: Hypomethylating Agents or Cytotoxic Treatment?. Front. Oncol. 2021;11
    https://doi.org/10.3389/fonc.2021.801524
  4. Lionel Adès, Larisa Girshova, Vadim A. Doronin, María Díez-Campelo, David Valcárcel, Suman Kambhampati, Nora-Athina Viniou, Dariusz Woszczyk, Raquel De Paz Arias, Argiris Symeonidis, Achilles Anagnostopoulos, Eduardo Ciliao Munhoz, Uwe Platzbecker, Valeria Santini, Robert J. Fram, Ying Yuan, Sharon Friedlander, Douglas V. Faller, Mikkael A. Sekeres. Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS/chronic myelomonocytic leukemia or low-blast-percentage AML. 2022;6:5132
    https://doi.org/10.1182/bloodadvances.2022007334
  5. A. M. E. Maraglino, V. Amato, S. Sammassimo, F. Gigli, V. Tabanelli, R. Pastano, C. Tarella, F. Giglio, E. Derenzini. Non-hepatosplenic extramedullary manifestations in patients affected by Chronic myelomonocytic leukemia. Case report and meta-analysis of the published series. Leukemia & Lymphoma 2023;64:1719
    https://doi.org/10.1080/10428194.2023.2234524
  6. Harinder Gill, Yammy Yung, Cherry Chu, Amber Yip. Pathogenesis and Treatment of Leukemia. 2023.
    https://doi.org/10.1007/978-981-99-3810-0_30
  7. Pranav Pramod Patwardhan, Mahmoud Aarabi, Nidhi Aggarwal. Genomics of myelodysplastic/myeloproliferative neoplasm. Seminars in Diagnostic Pathology 2023;40:195
    https://doi.org/10.1053/j.semdp.2023.04.005
  8. Harinder Gill, Yammy Yung, Cherry Chu, Amber Yip. Pathogenesis and Treatment of Leukemia. 2023.
    https://doi.org/10.1007/978-981-99-3810-0_34
  9. Shekhar Gurung, Saurab Karki, Manoj Khadka, Bhuwan Bhatta, Ayush Adhikari, Amar N. Shrestha. Chronic myelomonocytic leukemia in a 72-year-old male from Nepal: A case report. 2023;85:257
    https://doi.org/10.1097/MS9.0000000000000198
  10. Ghadir M Nasreddine, Solay Farhat, Zeinab M Hammoud, Firas Saad, Wajih Saad. Chronic Myelomonocytic Leukemia-Associated Immune Thrombocytopenic Purpura: A Report of a Rare Case and a Review of Literature. 2024
    https://doi.org/10.7759/cureus.55904
  11. Chao Wang, Zhiqiong Wang, Fankai Meng, Li Luo, Xian Liu, Jiayu Shi, Lifang Huang. Treatment Outcomes and Prognostic Factors in 66 Patients with Chronic Myelomonocytic Leukemia (CMML) in a Single Center. IJGM 2022;Volume 15:7843
    https://doi.org/10.2147/IJGM.S371766
  12. Francesco Tarantini, Cosimo Cumbo, Luisa Anelli, Antonella Zagaria, Nicoletta Coccaro, Giuseppina Tota, Giorgina Specchia, Pellegrino Musto, Francesco Albano. Clonal hematopoiesis in clinical practice: walking a tightrope. Leukemia & Lymphoma 2022;63:2536
    https://doi.org/10.1080/10428194.2022.2087068
© 2024. BLOOD RESEARCH All rights reserved. Powered by INFOrang Co., Ltd